Evidence map›Paper›PMID 33382695›Full record

ArticlePloS one2020

Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice.

Manvi Sharma, Itika Arora, Matthew L Stoll, Yuanyuan Li, Casey D Morrow, Stephen Barnes, Taylor F Berryhill, Shizhao Li, Trygve O Tollefsbol

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Manvi SharmaDepartment of Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0003-3625-3977
Itika AroraDepartment of Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0003-3761-4455
Matthew L StollDivision of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Yuanyuan LiDepartment of Obstetrics, Gynecology & Women's Heath, University of Missouri, Columbia, Missouri, United States of America.
Casey D MorrowDepartment of Cell, Developmental & Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Stephen BarnesComprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Taylor F BerryhillTargeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Shizhao LiDepartment of Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0002-3464-1450
Trygve O TollefsbolDepartment of Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID 0000-0002-0284-1511
University of Alabama at Birmingham · USTarget (United States) · USUniversity of Missouri · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
Combinatorial epigenetic-based prevention of breast cancerR01CA178441 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TOLLEFSBOL, TRYGVE O · 2014 to 2025
$3.2M
Early life prevention of breast cancer with combined epigenetic botanicalsR01CA204346 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TOLLEFSBOL, TRYGVE O · 2017 to 2021
$1.7M
Epigenetic mechanisms of maternal diets in human health and disease preventionK01AT009373 · NCCIH · UNIVERSITY OF MISSOURI-COLUMBIA · PI LI, YUANYUAN · 2017 to 2021
$569k
NCCIH NIH HHS K01 AT009373NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA178441NCI NIH HHS R01 CA204346NIDDK NIH HHS P30 DK056336
6 · The paper itself

Abstract

Breast cancer is the second leading cause of cancer-related mortality in women. Various nutritional compounds possess anti-carcinogenic properties which may be mediated through their effects on the gut microbiota and its production of short-chain fatty acids (SCFAs) for the prevention of breast cancer. We evaluated the impact of broccoli sprouts (BSp), green tea polyphenols (GTPs) and their combination on the gut microbiota and SCFAs metabolism from the microbiota in Her2/neu transgenic mice that spontaneously develop estrogen receptor-negative [ER(-)] mammary tumors. The mice were grouped based on the dietary treatment: control, BSp, GTPs or their combination from beginning in early life (BE) or life-long from conception (LC). We found that the combination group showed the strongest inhibiting effect on tumor growth volume and a significant increase in tumor latency. BSp treatment was integrally more efficacious than the GTPs group when compared to the control group. There was similar clustering of microbiota of BSp-fed mice with combination-fed mice, and GTPs-fed mice with control-fed mice at pre-tumor in the BE group and at pre-tumor and post-tumor in the LC group. The mice on all dietary treatment groups incurred a significant increase of Adlercreutzia, Lactobacillus genus and Lachnospiraceae, S24-7 family in the both BE and LC groups. We found no change in SCFAs levels in the plasma of BSp-fed, GTPs-fed and combination-fed mice of the BE group. Marked changes were observed in the mice of the LC group consisting of significant increases in propionate and isobutyrate in GTPs-fed and combination-fed mice. These studies indicate that nutrients such as BSp and GTPs differentially affect the gut microbial composition in both the BE and LC groups and the key metabolites (SCFAs) levels in the LC group. The findings also suggest that temporal factors related to different time windows of consumption during the life-span can have a promising influence on the gut microbial composition, SCFAs profiles and ER(-) breast cancer prevention.

Indexed as

ActinobacteriaAnimalsBrassicaDietErb-b2 Receptor Tyrosine KinasesEubacterialesFatty Acids, VolatileFemaleGastrointestinal MicrobiomeGene ExpressionLactobacillusMammary Glands, AnimalMammary Neoplasms, ExperimentalMiceMice, KnockoutPolyphenolsErbb2 protein, mouseErb-b2 Receptor Tyrosine KinasesFatty Acids, VolatilePolyphenolsReceptors, EstrogenTea

Identifiers

PMID33382695
PMCPMC7774855
OpenAlexW3115561157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.